Related Experiment Video
Updated: Jul 12, 2025

09:00
Biochemical Purification and Proteomic Characterization of Amyloid Fibril Cores from the Brain
Published on: April 28, 2022
3.2K
iAMY-RECMFF: Identifying amyloidgenic peptides by using residue pairwise energy content matrix and features fusion
Zizheng Yu1, Zhijian Yin1,2, Hongliang Zou1,2
1School of Communications and Electronics Jiangxi, Science and Technology Normal University, Nanchang 330013, P. R. China.
Journal of Bioinformatics and Computational Biology
|October 29, 2023
Summary
A new machine learning model, iAMY-RECMFF, accurately identifies amyloidogenic peptides, which are linked to diseases like Alzheimer's. This computational approach offers a faster, cost-effective alternative to experimental methods for distinguishing amyloid from non-amyloid proteins.
Area of Science:
- Biochemistry and computational biology
- Protein structure and function analysis
- Machine learning in bioinformatics
Background:
- Amyloid proteins are implicated in neurodegenerative diseases such as Alzheimer's, Huntington's, and Parkinson's.
- Distinguishing amyloidogenic from non-amyloidogenic peptides is crucial for understanding disease mechanisms.
- Experimental methods for amyloid identification are often expensive and time-consuming.
Purpose of the Study:
- To develop a novel machine learning framework, iAMY-RECMFF, for accurate discrimination of amyloidogenic peptides.
- To provide a computationally efficient and cost-effective tool for identifying amyloidogenic sequences.
- To enhance the understanding of peptide characteristics that confer amyloidogenicity.
Main Methods:
- Peptide sequences were encoded using a residue pairwise energy content matrix.
- Feature extraction involved Pearson's correlation coefficient and distance correlation.
- An improved similarity network fusion algorithm integrated multi-perspective features.
- The Fisher approach was used for optimal feature subset selection.
- A support vector machine classifier was employed for final identification.
Main Results:
- The iAMY-RECMFF framework demonstrated significantly improved accuracy in identifying amyloidogenic peptides.
- The developed method outperformed existing predictors in discrimination tasks.
- The feature selection and integration strategy proved effective for this classification problem.
Conclusions:
- The iAMY-RECMFF model serves as a powerful and efficient tool for identifying amyloidogenic peptides.
- This computational approach can accelerate research into amyloid-related diseases.
- The study provides accessible code and datasets for further academic research.
Keywords:
Amyloidgenic peptidesPearson’s correlation coefficientdistance correlationresidue pairwise energy content matrixsimilarity network fusion algorithmMore Related Videos
Related Concept Videos
Peptide Identification Using Tandem Mass Spectrometry
6.5K
Tandem mass spectrometry, also known as MS/MS or MS2, is an analytical technique that employs two mass analyzers. Essentially it is a series of mass spectrometers that helps isolate a particular biomolecule and then helps study its chemical properties.
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...
6.5K
Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K

